CHEMORADIATION IN NASOPHARYNGEAL CARCINOMA: A 6-YEAR EXPERIENCE IN TEHRAN CANCER INSTITUTE

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

KALAGHCHI BITA; KAZEMIAN ALI; AMOUZEGAR HASHEMI FARNAZ; AGHILI MEHDI; FARHAN FARSHID; HADDAD PEIMAN

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: ACTA MEDICA IRANICA Year:2011 | Volume:49 | Issue:1 Page(s): 49-53

Download Full-Text

View:

272

Download:

Cites:

Information Journal Paper

Title

CHEMORADIATION IN NASOPHARYNGEAL CARCINOMA: A 6-YEAR EXPERIENCE IN TEHRAN CANCER INSTITUTE

Author(s)

Keywords

NASOPHARYNGEAL NEOPLASMS

RADIOTHERAPY

CHEMOTHERAPY

Abstract

To determine the addition of value of neoadjuvant, concurrent and adjuvant CHEMOTHERAPY to radiation in the treatment of nasopharyngeal carcinoma with regard to the overall survival (OS) and disease free survival (DFS) within a six year period in Tehran cancer institute. Files of all patients with nasopharyngeal carcinoma treated by RADIOTHERAPY with or without concurrent CHEMOTHERAPY in a curative setting in Tehran cancer institute during the period of 1999-2005 were retrospectively reviewed.. A total of 103 patients with nasopharyngeal carcinoma had been treated during the study period with RADIOTHERAPY or chemoradiotherapy in our institute. There were 29 (28.2%) females and 74 (71.8%) males. The median age at the time of RADIOTHERAPY was 47 years old (range 9-75 years). The patients were followed 2 to 76 months with a median follow-up of 14 months. Time of first recurrence after treatment was 3-44 months with a median of 10 months.. Survival in 2 groups of patients treated with RADIOTHERAPY alone or chemoradiation did not have a significant difference (P>0.1). Two-year survival in patients treated with or without adjuvant CHEMOTHERAPY and had local recurrence after treatment did not have significant difference (P>0.1). Two-year survival in patients with or without local recurrence after treatment did not have significant difference (P>0.1). A beneficial affect or a survival benefit of adjuvant/neoadjuvant CHEMOTHERAPY and concurrent chemoradiation was not observed in Iranian patients.

Cites

No record.

References

No record.

Cite

APA: Copy

KALAGHCHI, BITA, KAZEMIAN, ALI, AMOUZEGAR HASHEMI, FARNAZ, AGHILI, MEHDI, FARHAN, FARSHID, & HADDAD, PEIMAN. (2011). CHEMORADIATION IN NASOPHARYNGEAL CARCINOMA: A 6-YEAR EXPERIENCE IN TEHRAN CANCER INSTITUTE. ACTA MEDICA IRANICA, 49(1), 49-53. SID. https://sid.ir/paper/278422/en

Vancouver: Copy

KALAGHCHI BITA, KAZEMIAN ALI, AMOUZEGAR HASHEMI FARNAZ, AGHILI MEHDI, FARHAN FARSHID, HADDAD PEIMAN. CHEMORADIATION IN NASOPHARYNGEAL CARCINOMA: A 6-YEAR EXPERIENCE IN TEHRAN CANCER INSTITUTE. ACTA MEDICA IRANICA[Internet]. 2011;49(1):49-53. Available from: https://sid.ir/paper/278422/en

IEEE: Copy

BITA KALAGHCHI, ALI KAZEMIAN, FARNAZ AMOUZEGAR HASHEMI, MEHDI AGHILI, FARSHID FARHAN, and PEIMAN HADDAD, “CHEMORADIATION IN NASOPHARYNGEAL CARCINOMA: A 6-YEAR EXPERIENCE IN TEHRAN CANCER INSTITUTE,” ACTA MEDICA IRANICA, vol. 49, no. 1, pp. 49–53, 2011, [Online]. Available: https://sid.ir/paper/278422/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops